Posted in What

What is Cara company?

   October 16, 2022

What is Cara company?

About us. Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.

Is cardiol Therapeutics a strong buy?

Is CARDIOL THERAPEUTICS Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: CRDL) stock is to Strong Buy CRDL stock.

Is Cara Therapeutics a good investment?

The financial health and growth prospects of CARA, demonstrate its potential to underperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.

What is KORSUVA?

KORSUVA is a kappa opioid receptor agonist indicated for the treatment of. moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD). (

Why did Cara Therapeutics drop?

What happened. Shares of Cara Therapeutics (CARA -4.85%) had plunged 27.8% lower as of 10:54 a.m. EST on Tuesday. The big drop came after the drugmaker announced results from a phase 2 clinical study evaluating Oral Korsuva in treating chronic kidney disease (CKD) patients with moderate to severe pruritis (itching).2019-12-03

Where is Cara Therapeutics located?

Shelton, Connecticut

Will CARA stock go up?

The 8 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +236.24% increase from the last price of 8.03.

Is Antibe Therapeutics a good buy?

Antibe Therapeutics has received a consensus rating of Buy. The company’s average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

READ  What happens if a blood sample is hemolyzed?

Is TARA a good stock?

Protara Therapeutics Inc (NASDAQ:TARA) The 4 analysts offering 12-month price forecasts for Protara Therapeutics Inc have a median target of 36.00, with a high estimate of 50.00 and a low estimate of 32.00. The median estimate represents a +961.95% increase from the last price of 3.39.

Is Unicycive Therapeutics a good stock to buy?

Unicycive Therapeutics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Is rain Therapeutics a buy?

Rain Therapeutics has received a consensus rating of Buy. The company’s average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

What happened to Antibe Therapeutics?

On , Antibe Therapeutics has moved to the TSX. In February 2021, Antibe announced a deal with Nuance Pharma, a Chinese pharmaceutical company, entitling them to $100 million in funding, with $20 million upfront. Antibe’s products have not yet been approved by the US Food and Drug Administration.

Is cardiol Therapeutics stock a good buy?

Cardiol Therapeutics has received a consensus rating of Buy. The company’s average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

Where is Cara Therapeutics based?

Stamford

Is Eliem Therapeutics stock a good buy?

Eliem Therapeutics has received a consensus rating of Buy. The company’s average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

Is Cara Therapeutics a buy?

Cara Therapeutics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

READ  What is Brad Pitt's net worth in 2020?

What is KORSUVA used for?

Korsuva is a prescription medicine used to treat the symptoms of moderate-to-severe Itching associated with chronic kidney disease in adults undergoing hemodialysis (HD). Korsuva may be used alone or with other medications. Korsuva belongs to a class of drugs called Kappa Opioid Receptor Agonists.

Used Resourses:

Author: whoiswh